Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis.
about
Silencing of the XAF1 gene by promoter hypermethylation in cancer cells and reactivation to TRAIL-sensitization by IFN-betaInvolvement of Noxa in cellular apoptotic responses to interferon, double-stranded RNA, and virus infectionRole of DNA methylation in renal cell carcinomaAcute induction of cell death-related IFN stimulated genes (ISG) differentiates highly from moderately virulent CSFV strainsCritical roles for IFN-beta in lymphoid development, myelopoiesis, and tumor development: links to tumor necrosis factor alphaInterferon and granulopoiesis signatures in systemic lupus erythematosus bloodAbsence of gene mutation in TRAIL receptor 1 (TRAIL-R1) and TRAIL receptor 2 (TRAIL-R2) in chronic myelogenous leukemia and myelodysplastic syndrome, and analysis of mRNA Expressions of TRAIL and TRAIL-related genes in chronic myelogenous leukemia.Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer.Small non-coding RNAs encoded within the herpes simplex virus type 1 latency associated transcript (LAT) cooperate with the retinoic acid inducible gene I (RIG-I) to induce beta-interferon promoter activity and promote cell survival.The elusive chronic myeloid leukemia stem cell: does it matter and how do we eliminate it?Domain organization of XAF1 and the identification and characterization of XIAP(RING) -binding domain of XAF1.XAF1 directs apoptotic switch of p53 signaling through activation of HIPK2 and ZNF313XAF1 expression and regulatory effects of somatostatin on XAF1 in prostate cancer cells.HSF1 down-regulates XAF1 through transcriptional regulation.Promoter CpG hypermethylation and downregulation of XAF1 expression in human urogenital malignancies: implication for attenuated p53 response to apoptotic stresses.IFN-zeta/ limitin: a member of type I IFN with mild lympho-myelosuppression.Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex.De novo assembly and transcriptome analysis of Atlantic salmon macrophage/dendritic-like TO cells following type I IFN treatment and Salmonid alphavirus subtype-3 infection.Interferon targeted genes in host defense.Two microRNAs encoded within the bovine herpesvirus 1 latency-related gene promote cell survival by interacting with RIG-I and stimulating NF-κB-dependent transcription and beta interferon signaling pathways.Diversity in Compartmental Dynamics of Gene Regulatory Networks: The Immune Response in Primary Influenza A Infection in Mice.Epigenetic silencing of the XAF1 gene is mediated by the loss of CTCF binding.Anticancer activity of oncolytic adenovirus vector armed with IFN-alpha and ADP is enhanced by pharmacologically controlled expression of TRAILGene expression profiling in human autoimmunity.Tumor suppression in mice lacking GABARAP, an Atg8/LC3 family member implicated in autophagy, is associated with alterations in cytokine secretion and cell death.Augmentation of effects of interferon-stimulated genes by reversal of epigenetic silencing: potential application to melanoma.Big wheel keeps on turning: apoptosome regulation and its role in chemoresistance.ZNF313 is a novel cell cycle activator with an E3 ligase activity inhibiting cellular senescence by destabilizing p21(WAF1.).MicroRNA expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patientsIAP-targeted therapies for cancer.Inhibitor of apoptosis proteins in hematological malignancies.High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression.TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma.c-Jun N-terminal kinase (JNK1) upregulates XIAP-associated factor 1 (XAF1) through interferon regulatory factor 1 (IRF-1) in gastrointestinal cancer.Combination treatment of human umbilical cord matrix stem cell-based interferon-beta gene therapy and 5-fluorouracil significantly reduces growth of metastatic human breast cancer in SCID mouse lungs.Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.Restoring PU.1 induces apoptosis and modulates viral transactivation via interferon-stimulated genes in primary effusion lymphoma.Potent antitumor efficacy of XAF1 delivered by conditionally replicative adenovirus vector via caspase-independent apoptosis.Interferon-alpha induces sensitization of cells to inhibition of protein synthesis by tumour necrosis factor-related apoptosis-inducing ligand.Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
P2860
Q21260407-170C454E-8F9F-4D8F-A120-093F1134DF1AQ24294698-907509ED-2654-4AB6-BFF4-173E89B6A36FQ26801268-C8E85BFA-0C79-4D52-BDB9-0CF8D270DE79Q27490370-F34B6B0F-7DBA-4747-BE68-5726F810051FQ28511726-CE108D08-5A03-4844-A37E-ED7CC8BE9EE0Q29615064-0870F262-7126-4121-904F-A5B175195BCDQ33213461-A0DF0FAD-C58F-4FCC-A808-DC10D728AA3EQ33491820-6B09A8A2-C9B9-432C-9967-549A7982C1D7Q33820678-C010EFCC-9AB1-46F3-A8D1-3C6E11E9D8E1Q34167708-1974BA65-313F-47C9-B692-ADB21926EE01Q34343401-168BF566-6563-4A46-9903-FADFA94C0F57Q34441993-8180F5C0-C48E-40CF-ADC9-DEAF74C4B151Q34448027-88DD7B5A-B393-4749-81E6-3421107509DDQ34469575-AA2599E0-E28C-4D3A-AC17-9062BFBCD07BQ34557323-287BE441-E6F5-4F24-8D03-E5BBC3AC4662Q34558610-6E5AA2F8-D559-411B-B147-E10BC48B93C0Q34646527-97D73A77-5D1C-4B21-A8E3-E218F308A65EQ35109562-BBAA5561-838A-4A78-81C8-BCE7A5C690CCQ35675514-DC44792D-DB2E-4491-8621-F2231B7E3AAEQ35689581-9B18B4C2-C6BA-497E-B973-1104C223155AQ35790294-C5A0CE23-13D8-46B9-AE5B-B68B9137F301Q36129174-179D6170-5272-4929-81BC-66363D2CE626Q36209190-C634602E-A88D-4EFD-A5B0-C5BDF36D449FQ36453363-34797939-4957-4D71-8FC5-A16F6FD88266Q36866484-6B9BE342-DEF8-439A-9ADB-61AA5BD28B0BQ36906147-A439246B-011E-4F11-8938-B166892BCCF8Q36988138-A01A15EE-7B5F-4D4C-B958-7F8258209C53Q36994782-E1D04836-CC3E-48A7-9DE3-C7887E356D47Q37139127-AAC02378-5E95-4DCC-9973-C0AAAAAB5C16Q37302745-F2455242-E923-460D-B082-4DEB6AD6029EQ37336610-E482A648-96E0-4655-81BE-FCF85DD35F03Q38725533-8BC41FE3-18F3-451B-875E-E5F0C56A6FC8Q39905680-C48489A3-B89C-45EF-A101-A266D377AA8DQ39908683-DB244A98-004E-4085-B46A-A8A93BD532A9Q39963975-C0E2CC14-EA4B-4CEB-BE6F-F7EB351542E9Q40102556-6D8E2DA5-0C2B-4DA1-924C-521D43FF214DQ40210866-A955D0F4-8B66-49EE-A715-E66325125D45Q40226159-42F3EEEA-9293-47BD-9B73-E90E28E2EE60Q40243488-3486FCD0-3BF1-4E3D-AF11-B6C542AA5743Q40563380-757E160D-B8B9-4EF9-931C-16E280B1550E
P2860
Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Identification of X-linked inh ...... TRAIL Apo2L-induced apoptosis.
@ast
Identification of X-linked inh ...... TRAIL Apo2L-induced apoptosis.
@en
Identification of X-linked inh ...... TRAIL Apo2L-induced apoptosis.
@nl
type
label
Identification of X-linked inh ...... TRAIL Apo2L-induced apoptosis.
@ast
Identification of X-linked inh ...... TRAIL Apo2L-induced apoptosis.
@en
Identification of X-linked inh ...... TRAIL Apo2L-induced apoptosis.
@nl
prefLabel
Identification of X-linked inh ...... TRAIL Apo2L-induced apoptosis.
@ast
Identification of X-linked inh ...... TRAIL Apo2L-induced apoptosis.
@en
Identification of X-linked inh ...... TRAIL Apo2L-induced apoptosis.
@nl
P2093
P2860
P356
P1476
Identification of X-linked inh ...... TRAIL Apo2L-induced apoptosis.
@en
P2093
Douglas W Leaman
Ernest C Borden
Katsuyuki Tamai
Keyur Vyas
Monila Reheman
Singo Toji
P2860
P304
28504-28511
P356
10.1074/JBC.M204851200
P407
P577
2002-05-23T00:00:00Z